Skip to content

Transcutaneous spinal direct current stimulation in symptomatic management of patients with diabetic polyneuropathy

Transcutaneous spinal direct current stimulation in symptomatic management of patients with diabetic polyneuropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00013525
Enrollment
50
Registered
2018-03-13
Start date
2018-03-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G63.2

Interventions

Group 1: Anodal stimulation tsDCS (20min, 2,5mA) for 50 patients with dPN (diabetic polyneuropathy) in a crossover-Design. Results of pain questionnaires as well as results of a clinical examination (

Sponsors

Klinik für Anästhesiologie, Intensiv-, Palliativ- und Schmerzmedizin; Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Bochum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Voluntariness; age >18 years at time of examination; proficient german language skils; ability to fully understand the type and purpose of this study; ability to cooperate with the research-team and fulfill all requirements of the study; diabetes mellitus with diabetic polyneuropathy and: 1. pain in the lower extremity or paresthesia in the lower extremity and 2. HbA1c <8,5% (recorded in the last six weeks); informed consent (written).

Exclusion criteria

Exclusion criteria: Withdrawal of the informed consent; psychiatric disease; neurological comorbidity; change in medication in the preceding six weeks (e.g. antidiabetics, antidepressants, analgetics or other centrally active substances); employees of the principal investigator who is conducting and/or participating in this or in other studies; needle EMG: wound healing disorders, diabetic foot syndrome; cardiac pacemaker; secondary exclusion criteria: change in medication between the two examinations.

Design outcomes

Primary

MeasureTime frame
Intensity of pain in patients affected by dPN, measured by Numeric Rating Scale (NRS 0-10), during the control-examination directly after stimulation, 30 min and 24h later.

Secondary

MeasureTime frame
Degree of paresthesia in patients (Score 0-10 with the paresthesia questionaire, quality of sleep (equal, better, worse) and sensibility with the NDS-Score and a clinical examination are examined directly, 30min and 24h after stimulation.

Countries

Germany

Contacts

Public ContactChristine Meyer-Frießem

Klinik für Anästhesiologie, Intensiv-, Palliativ- und Schmerzmedizin; Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Bochum

meyer-friessem@ains-bergmannsheil.de0049234-3020

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026